View, browse, and sort the education offerings, networking opportunities, and event activities by using the filters below; you can search by Pass Type, Free Content & Activities, and Conference Track. With this session scheduler, you can build your daily agenda in advance and access the full list of options during the event. Sessions do fill up and seating is first come/first serve, so please arrive early to sessions that you would like to attend.
David L. Lucchino is long-time leader in Kendall Square, the world's most dynamic life science community, located in Cambridge, Massachusetts. As an entrepreneur with a 22-year track record, Mr. Lucchino has co-founded, built, advanced and sold several companies that emerged from the famed lab of MIT Institute Professor Robert S. Langer, Sc.D. In March 2018, Mr. Lucchino will become the chairman of MassBio, the voice of the life sciences industry in Massachusetts comprising more than 1,100 companies as well as hospitals, universities and healthcare organizations. Mr. Lucchino currently serves as co-founder, president and CEO of Frequency Therapeutics, a clinical-stage biotechnology company developing small molecule drug treatments with an initial focus on restoring hearing to those affected by chronic, noise-induced hearing loss, a condition that affects 50 million Americans. Frequency's Progenitor Cell Activation (PCA) platform has the potential to reactivate dormant cells in many parts of the body, providing disease-modifying therapy for a potentially wide range of degenerative conditions. The company's second program is in alopecia. PCA Regeneration is a platform technology founded on discoveries in stem cell biology by co-founder Dr. Langer and Jeff Karp, Ph.D., of Harvard Medical School. Mr. Lucchino was recently accepted into the American Institute for Medical and Biomedical Engineering (AIMBE) College of Fellows, and was appointed by Massachusetts Governor Charlie Baker to serve on the Department of Labor Relations Advisory Council. Mr. Lucchino earned a B.A. from Denison University, an M.S. from the Newhouse School of Journalism at Syracuse University, and an M.B.A. from MIT's Sloan School of Management. David has been selected for numerous awards and honors, and is a sought-after lecturer and mentor in business organizations and academic institutions.